Joensuu et al. performed an immunohistochemical analysis of 72 primary BC tissue samples and found that the expression levels of STC‐1 and STC‐2 in metastases at 5 and 10 years after surgery were significantly higher than those in early metastases.15 Here, STC1 is linked to breast cancer.